(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






19 Result: Tesla

Countdown to Earnings: Tesla, Abbott Laboratories, and IBM Take the Stage

January 21st, 2024

On Wednesday, January 24, a lineup of major companies is set to reveal their financial performances: Tesla, Inc. (Nasdaq: TSLA), the electric vehicle and clean energy company, will release its financial results for the fourth quarter of 2023 after. Read more

Breaking: Tesla and Equifax Miss Wall Street Estimates

October 18th, 2023

Tesla, Inc. (Nasdaq: TSLA), an electric vehicle and clean energy company, posted third-quarter 2023 earnings of $0.66 per share, falling short of the consensus EPS estimate of $0.73. The company's quarterly sales totaled $23.35 billion, below analyst. Read more

Earnings Countdown: Tesla, ASML Holding, and Netflix Take Center Stage

October 14th, 2023

On Wednesday, October 18, the spotlight turns to these key companies as they prepare to unveil their financial results: Tesla, Inc. (Nasdaq: TSLA), the renowned electric vehicle manufacturer, is poised to post its financial results for the third q. Read more

Momentum: Crinetics' Acromegaly Study Data and Tesla's Morgan Stanley Boost

September 11th, 2023

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) has reported promising results from its Phase 3 PATHFNDR-1 study evaluating paltusotine, an oral once-daily investigational compound designed for acromegaly treatment. The study achieved its primary endp. Read more

Tesla's IP Protection Strengthened; Bullish View On SoundHound AI

September 05th, 2023

Tesla, Inc. (Nasdaq: TSLA), a leading electric vehicle and clean energy company, has been granted two new patents by the United States Patent and Trademark Office (USPTO): - Patent No. US-11749842-B2, titled "Cell with a tabless electrode" and; . Read more

Q2 Earnings Beat: Tesla and Las Vegas Sands

July 20th, 2023

Tesla, Inc. (Nasdaq: TSLA) has released its second-quarter 2023 financial results, surpassing earnings expectations with an adjusted EPS of $0.91 compared to the consensus estimate of $0.82. The company's quarterly revenues surged 47% year-over-year . Read more

Tesla: Key Upcoming Date; Market Experts Bullish On Keysight and Carnival

July 02nd, 2023

Tesla, Inc. (Nasdaq: TSLA) announced its vehicle production and deliveries for the second quarter of 2023. The company produced 479,700 vehicles and delivered 466,140 vehicles during this period, marking an increase from the previous quarter's produc. Read more

Breaking: AeroVironment, Transphorm, and Tesla - Market Movers

June 27th, 2023

AeroVironment, Inc. (Nasdaq: AVAV) reported fourth-quarter fiscal 2023 adjusted EPS of $0.99, slightly below the consensus estimate of $1.01. Looking ahead to the full-year fiscal 2024, the company anticipates revenue ranging between $630 million . Read more

EV Market Shakers: XPeng G6 Launch and Tesla's Downgrade

June 26th, 2023

XPeng Inc. (NYSE: XPEV), a leading Chinese electric vehicle manufacturer, is poised to have a significant impact on the automotive market with the highly anticipated launch of its XPENG G6 Ultra Smart Coupe SUV. This revolutionary vehicle, developed . Read more

Market Shakers: GMS, T2 Biosystems, Tesla, and Palantir Make Waves

June 22nd, 2023

GMS Inc. (NYSE: GMS) announced its fourth-quarter fiscal 2023 results, surpassing expectations with an adjusted EPS of $2.11 compared to the consensus estimate of $1.89. The company reported quarterly sales of $1.30 billion, exceeding the consensus r. Read more

Nuwellis and DaVita Strike Deal, Rivian Secures Tesla's Supercharger Network Access

June 20th, 2023

Nuwellis, Inc. (Nasdaq: NUWE) has partnered with DaVita Inc. (NYSE: DVA) through a Supply and Collaboration Agreement to introduce Aquadex ultrafiltration therapy for the treatment of adult patients with congestive heart failure in select U.S. market. Read more

Patent Power: Tesla Expands IP Protection, Alibaba Shifts Leadership

June 20th, 2023

Tesla, Inc. (Nasdaq: TSLA), a renowned electric vehicle and clean energy company, is increasing the protection of its intellectual property with two new patents awarded by The United States Patent and Trademark Office (USPTO). The first patent, No. Read more

Tesla Granted U.S. Patent; Analysts Optimistic On Ulta Beauty, Roblox, and Alight

June 13th, 2023

Tesla, Inc. (Nasdaq: TSLA), a renowned electric vehicle and clean energy company, has been awarded U.S. Patent No. US 11,675,358 B2 by The United States Patent and Trademark Office (USPTO).  This patent, titled "Autonomous driving system emer. Read more

Triple Impact: iBio's Collaboration, Oracle's Strong Q4, and EVgo's Charging Network Growth Make Waves

June 12th, 2023

iBio, Inc. (NYSE American: IBIO) has partnered with the National Institute of Allergy and Infectious Diseases (NIAID) to explore the potential of the company's AI-driven epitope steering platform in developing a vaccine for Lassa fever, a severe and . Read more

23andMe: Strategic Move; Oracle, Tesla and Microsoft: PT Boost Hint at Potential Upsides

June 09th, 2023

23andMe Holding Co. (Nasdaq: ME), a leading genetic testing and personal genomics company, has disclosed in a regulatory filing with the SEC a reduction in force involving around 75 employees, representing approximately 9% of its workforce.  . Read more

Load More Content